AEV
0.009
50%
KFM
0.061
-21.8%
VTA
0.021
31.3%
CMO
0.004
-20%
HIQ
0.005
25%
SRJ
0.004
-20%
VKA
0.011
22.2%
DTZ
0.026
-18.8%
WCN
0.023
21.1%
TZN
0.019
-17.4%
A8G
0.21
20%
FAU
0.01
-16.7%
MGU
0.006
20%
PL9
0.005
-16.7%
ABE
0.037
19.4%
UNT
0.005
-16.7%
JAV
0.097
18.3%
BRY
0.011
-15.4%
HMD
0.039
18.2%
CMP
0.235
-14.5%
SLA
0.13
18.2%
AGN
0.15
-14.3%
NYM
0.053
17.8%
GEN
0.006
-14.3%
EAU
0.14
16.7%
LRM
0.018
-14.3%
INF
0.007
16.7%
M4M
0.006
-14.3%
XST
0.014
16.7%
X2M
0.006
-14.3%
KLI
0.325
16.1%
SLB
0.275
-14.1%
HVY
0.4
15.9%
NOX
0.065
-13.3%
REC
0.037
15.6%
AS2
0.007
-12.5%
AHE
0.015
15.4%
AUV
0.007
-12.5%
DRX
0.016
14.3%
MRD
0.042
-12.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CMP FDA clearance

Compumedics (ASX:CMP) announces the US FDA has cleared the Somfit device to be marketed in the USA. This marks the achievement of another significant strategic milestone for the Somfit technology platform in one of the world’s largest sleep markets https://www.compumedics.com.au/en/asx-announcements/somfit-update2-2/ #shorts